Topic: venture investment
Hanmi loses Janssen obesity pact, while Yuhan signs NASH deal with Boehringer. GSK sells a Chinese site to Fosun as it opens facilities in Singapore.
Takeda investors worry about Shire's hemophilia products; Biocon's biosimilars plant clears the FDA; C-Bridge Capital invests $35 million in Nuance.
Rapid Micro Biosystems secured $60 million in financing to expand its global reach and develop new products.
6 Dimensions makes a slew of biotech investments; Sun Pharma wins FDA nod for Ilumya; China plans 'zero tariff' policy on cancer drugs.
Takeda-Zinfandel dropped an Alzheimer’s study; Shanghai Pharma will open an R&D site in the U.S.; NextCODE CEO talked about company plans.
Japan’s JSR bought Crown Biosciences, Aurobindo and Dr. Reddy’s responded to Orchid Pharma report, Tessa raised $80 million.
Young biotech Codagenix just secured $3 million in funding to advance its live-attenuated RSV vaccine candidate.
Startup iCarbonX has roped in $45 million from China Bridge Capital in the race to grow precision medicine offerings in China.
CStone Pharmaceuticals has raised $150 million in Series A funds to hunt for early stage candidates across therapeutic areas with immuno-oncology serving as a core focus.